This report analyzes the China Kidney Stone Management Devices market in terms of size, recent trends, driving factors, regional shares, and forecasts from 2020 to 2035.
The economic impact of tariffs on "China Kidney Stone Management Devices".
China Kidney Stone Management Devices Market Growth Drivers
Rising Prevalence of Kidney Stone Disease: The growing incidence of kidney stone cases in China, attributed to lifestyle changes, dietary habits, and increasing rates of obesity, is significantly driving demand for kidney stone management devices. Data from the Chinese Urological Association suggests a noticeable uptrend in kidney stone cases, leading to increased adoption of devices such as lithotripters and ureteroscopes. Companies like Boston Scientific Corporation are investing in advanced, minimally invasive urology products to cater to this rising patient pool.
Technological Advancements in Stone Removal Devices: Key market players such as Olympus Corporation and Dornier MedTech are innovating with next-generation devices, such as digital flexible ureteroscopes and high-frequency laser systems, which improve treatment precision and reduce patient recovery times. These advancements are making procedures safer, less invasive, and more effective, thus spurring market growth and facilitating the penetration of modern devices across China’s healthcare facilities.
China Kidney Stone Management Devices Market Trends
Growing Preference for Minimally Invasive Procedures: Hospitals and clinics in China are increasingly adopting minimally invasive solutions for kidney stone management to improve patient outcomes and reduce hospital stays. Companies like Stryker and Olympus have reported growth in the adoption of their ureteroscopes and laser lithotripsy systems, driven by the demand for faster recovery and fewer complications.
Expansion of Local Manufacturing and Distribution: Native Chinese medical device manufacturers are scaling up efforts to cater domestically and abroad, improving accessibility and affordability of kidney stone management devices. Shenzhen Mindray Bio-Medical Electronics and other local firms are expanding research and development, partnering with public hospitals, and facilitating better device distribution across tier-2 and tier-3 cities.
China Kidney Stone Management Devices Market Opportunity
Emergence of Artificial Intelligence in Diagnostics: There is significant opportunity for the integration of AI-driven imaging and diagnostic solutions to identify, localize, and characterize kidney stones more accurately. Companies like Siemens Healthineers are piloting AI-based platforms in Chinese hospitals, aimed at aiding urologists with enhanced diagnostic precision and treatment planning.
Public-Private Partnerships for Rural Healthcare Expansion: China's government initiatives to improve urological care in rural regions open up partnership opportunities for device manufacturers and distributors. Collaborations with entities like China Resources and Sinohealth are expected to expand access to modern kidney stone management technologies in underserved regions.
China Kidney Stone Management Devices Market Revenue (USD Million), 2020-2035
The chart reflects steady revenue growth from USD 800 million in 2020 to approximately USD 2,520 million by 2035, supported by rising disease prevalence, higher adoption of advanced devices, and improved access to urology services across China. The compound annual growth rate (CAGR) over the forecast period (2024-2035) is projected at around 10.7%. Early years show moderate growth, with a notable uptick post-2025 as healthcare reforms and domestic innovation bear fruit. The market’s resilience is reinforced by an expanding middle class and increased healthcare spending.
China Kidney Stone Management Devices Market by Regions Share (%), 2025
In 2025, the East China region dominates the market with a 37% share, owing to well-developed healthcare infrastructure and high urbanization rates. North China follows with a 22% share, while South China accounts for 18%. Central, West, and Northeast China are emerging markets but currently maintain lesser shares due to slower adoption of advanced devices and healthcare access disparities. Market share variations indicate key growth opportunities and the need for tailored regional expansion strategies for both global and domestic device manufacturers.
Recent Developments in China Kidney Stone Management Devices Market (Past 6 Months)
In April 2024, Boston Scientific China announced the commercialization of its advanced LithoVue Elite single-use digital flexible ureteroscope in multiple provinces, following CFDA approval. This device aims to provide enhanced navigation and visualization for kidney stone procedures, supporting infection control and reducing cross-contamination.
In March 2024, Mindray Bio-Medical partnered with several top-tier hospitals in Shanghai to introduce an AI-powered kidney stone detection and management module within its urology imaging solutions. The integration promises to reduce diagnostic times by up to 30%, representing a leap in workflow efficiency and reducing physician burnout.
In February 2024, Olympus (China) launched its latest pulsed laser lithotripsy platform, Soltive, at the China Medical Equipment Fair, positioning it as a minimally invasive and high-precision solution. Several leading Chinese urologists participated in live demonstrations, highlighting improved stone dusting capabilities and enhanced patient recovery outcomes.
Press Releases